Circadian as A Prognostic Factor For Radiation Response in Cervical Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
The study was a Randomized Clinical Trial (RCT) or clinical trial comparing the results of radiation treatment of 2 treatment groups, i.e. subject groups irradiated in the morning and in the afternoon, to check melatonin levels in cervical cancer patients. Since it is known that the function of melatonin is as an antiproliferation substance or hormone, induces apoptosis, inhibits invasion and metastasis.
Epistemonikos ID: 44f8a78378d83afac35ee9da36940ef024873811
First added on: May 13, 2024